FDA Clearance Tracker · P090016-S050
Belotero Balance (+) Lidocaine
Last checked: Nov 20, 2026Latest source record: Sep 27, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Sep 27, 2023
Approved
Time to decision
246 days
Received Jan 24, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P090016-S050
- Device name
- Belotero Balance (+) Lidocaine
- Applicant
- Merz North America, Inc.
- Applicant location
- Franksville, WI
- Received
- Jan 24, 2023
- Decided
- Sep 27, 2023
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P090016
Device type
- Device type
- Implant, dermal, for aesthetic use (LMH)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for Belotero Balance(R) (+) for Expanding the Indications to Include Volume Augmentation for the Improvement of the Infraorbital Hollow in Adults Over the Age of 21. This device is indicated for injection into the mid-to-deep dermis for correction of moderate-to-severe facial wrinkles and folds, such as nasolabial folds. The device is also indicated for volume augmentation for the improvement of the infraorbital hollow in adults over the age of 21.
Source documents
Other decisions for Merz North America, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P250016 · Decided Jul 9, 2026 · 387 days after receipt
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
P250020 · Decided May 19, 2026 · 327 days after receipt
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
- RADIESSE® Injectable ImplantPMA supplement
P050052-S162 · Decided Mar 31, 2026 · 678 days after receipt · Panel Track
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.